201 related articles for article (PubMed ID: 28482871)
1. Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.
Schüler-Toprak S; Moehle C; Skrzypczak M; Ortmann O; Treeck O
BMC Cancer; 2017 May; 17(1):319. PubMed ID: 28482871
[TBL] [Abstract][Full Text] [Related]
2. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.
Lattrich C; Stegerer A; Häring J; Schüler S; Ortmann O; Treeck O
Steroids; 2013 Feb; 78(2):195-202. PubMed ID: 23153457
[TBL] [Abstract][Full Text] [Related]
4. Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines.
Lattrich C; Schüler S; Häring J; Skrzypczak M; Ortmann O; Treeck O
Arch Gynecol Obstet; 2014 Jan; 289(1):163-71. PubMed ID: 23907354
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells.
Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O
BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
Liu J; Viswanadhapalli S; Garcia L; Zhou M; Nair BC; Kost E; Rao Tekmal R; Li R; Rao MK; Curiel T; Vadlamudi RK; Sareddy GR
Oncotarget; 2017 Jul; 8(30):50002-50014. PubMed ID: 28654894
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells.
Hinsche O; Girgert R; Emons G; Gründker C
Int J Oncol; 2015 Feb; 46(2):878-84. PubMed ID: 25420519
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.
Marzagalli M; Casati L; Moretti RM; Montagnani Marelli M; Limonta P
PLoS One; 2015; 10(7):e0134396. PubMed ID: 26225426
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic significance of estrogen receptor β agonists in gliomas.
Sareddy GR; Nair BC; Gonugunta VK; Zhang QG; Brenner A; Brann DW; Tekmal RR; Vadlamudi RK
Mol Cancer Ther; 2012 May; 11(5):1174-82. PubMed ID: 22442308
[TBL] [Abstract][Full Text] [Related]
11. Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy.
Ruddy SC; Lau R; Cabrita MA; McGregor C; McKay BC; Murphy LC; Wright JS; Durst T; Pratt MA
Mol Cancer Ther; 2014 Jul; 13(7):1882-93. PubMed ID: 24785256
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
13. Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.
Paruthiyil S; Cvoro A; Zhao X; Wu Z; Sui Y; Staub RE; Baggett S; Herber CB; Griffin C; Tagliaferri M; Harris HA; Cohen I; Bjeldanes LF; Speed TP; Schaufele F; Leitman DC
PLoS One; 2009 Jul; 4(7):e6271. PubMed ID: 19609440
[TBL] [Abstract][Full Text] [Related]
14. In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.
Colciago A; Ruscica M; Mornati O; Piccolella M; Montagnani-Marelli M; Eberini I; Festuccia C; Magni P; Motta M; Negri-Cesi P
Biomed Res Int; 2014; 2014():801473. PubMed ID: 24877132
[TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes.
Cvoro A; Tatomer D; Tee MK; Zogovic T; Harris HA; Leitman DC
J Immunol; 2008 Jan; 180(1):630-6. PubMed ID: 18097065
[TBL] [Abstract][Full Text] [Related]
16. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.
O'Donnell AJ; Macleod KG; Burns DJ; Smyth JF; Langdon SP
Endocr Relat Cancer; 2005 Dec; 12(4):851-66. PubMed ID: 16322326
[TBL] [Abstract][Full Text] [Related]
18. Indole Derivative Interacts with Estrogen Receptor Beta and Inhibits Human Ovarian Cancer Cell Growth.
Verardi L; Fiori J; Andrisano V; Locatelli A; Morigi R; Naldi M; Bertucci C; Strocchi E; Boga C; Micheletti G; Calonghi N
Molecules; 2020 Sep; 25(19):. PubMed ID: 32992652
[TBL] [Abstract][Full Text] [Related]
19. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells.
Kang SK; Choi KC; Tai CJ; Auersperg N; Leung PC
Endocrinology; 2001 Feb; 142(2):580-8. PubMed ID: 11159828
[TBL] [Abstract][Full Text] [Related]
20. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
